未登录

Y

Yu Mi

sun yat-sen university

H指数:21

被引数:1,868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Microbiota–Gut–Brain Axis in Autism: Associations, Causal Inference, and Interventions—A Narrative Review

自闭症中的微生物组-肠-脑轴：关联、因果推断与干预——一篇叙事性综述

Pathogens 2025, Vol. 14, Page 1145

IF3.3

2025-11-180

OAAI

Ginsenosides as Functional Foods: A Novel Approach for Regulating Gut Microbiota

人参皂苷作为功能食品：调节肠道菌群的一种新方法

ACS FOOD SCIENCE & TECHNOLOGY

IF2.8

2025-03-180

PRE

Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo (vol 16, 1906360, 2020)

纳米颗粒药物递送可降低治疗性载体的肝毒性 (vol 16, 1906360, 2020)

IF12.1

2025-01-100

PRE

Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models

ACTA BIOMATERIALIA

IF9.6

2021-04-0146

OAAI

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine

BIOCONJUGATE CHEMISTRY

IF3.9

2020-11-3015

OAAI

Neoantigen nanovaccine improves personalized cancer immunotherapy

CANCER RESEARCH

IF16.6

2020-08-151

PRE

Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo

IF12.1

2020-01-2318

OAAI

Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion

ADVANCED SCIENCE

IF14.1

2019-08-1316

OAAI

Nanoparticle reduces hepatotoxicity of cancer treatment by controlled release and Kupffer cell uptake

CANCER RESEARCH

IF16.6

2019-07-012

PRE

Emerging Nano-/Microapproaches for Cancer Immunotherapy

新兴的纳米/微米癌症免疫治疗方法

ADVANCED SCIENCE

IF14.1

2019-01-13134

OAAI

Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models

IF12.9

2018-07-0172

OAAI

A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy

双重免疫治疗纳米颗粒可改善T细胞活化和癌症免疫治疗

ADVANCED MATERIALS

IF26.8

2018-04-25168

OAAI

Spatial-temporal delivery of OX40 agonist and PD-1 inhibitor using nanoparticles improves therapeutic efficacy of cancer immunotherapy

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Enzyme-responsive multistage vector for drug delivery to tumor tissue

PHARMACOLOGICAL RESEARCH

IF10.5

2016-11-0152

OAAI

A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells

PHARMACOLOGICAL RESEARCH

IF10.5

2016-09-019

OAAI

A Micro/Nano Composite for Combination Treatment of Melanoma Lung Metastasis

ADVANCED HEALTHCARE MATERIALS

IF9.6

2016-02-1843

OAAI

Multimodality treatment of cancer by co-encapsulation of docetaxel and iron oxides in heceptin-conjugated nanoparticles of a blend of biodegradable copolymers

JOURNAL OF CONTROLLED RELEASE

IF11.5

2013-11-011

PRE

Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer

维生素e TPGS-顺铂前药纳米粒靶向共递送多西他赛、顺铂和赫赛汀治疗癌症

JOURNAL OF CONTROLLED RELEASE

IF11.5

2013-08-01148

PREAI

Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles

IF12.9

2013-04-0196

PREAI

Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2012-11-0187

PREAI